AK
Avadhesh Kumar Singh
About Avadhesh Kumar Singh
Data last updated:
Avadhesh Kumar Singh is a Director at Bioxtreme Pharma Private Limited (since 2021) and Director at Anshi Infratech Private Limited (since 2023). The companies operate in Healthcare. The largest current company by reported revenue is Bioxtreme Pharma Private Limited at ₹2.62 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 15 Apr 2021 | 2021 | ₹2.62 Cr (FY 2025) | Active | |
| Director | 05 Jun 2023 | 2023 | Active |
Board colleagues of Avadhesh Kumar Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kali Charan Jaiswal | 07043502 | Bioxtreme Pharma Private Limited | Director |
| Nihal Singh | 10191294 | Anshi Infratech Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Avadhesh Kumar Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Avadhesh Kumar Singh
Avadhesh Kumar Singh currently holds 2 directorships: Bioxtreme Pharma Private Limited (Director, since 15 Apr 2021, revenue ₹2.62 Cr (FY 2025)); Anshi Infratech Private Limited (Director, since 05 Jun 2023).
Avadhesh Kumar Singh was first appointed on 15 Apr 2021 as Director at Bioxtreme Pharma Private Limited. The most recent appointment on record is 05 Jun 2023 at Anshi Infratech Private Limited.
The current boards of Avadhesh Kumar Singh's companies include Kali Charan Jaiswal (Bioxtreme Pharma Private Limited), Nihal Singh (Anshi Infratech Private Limited).